The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular Disease
- 1 September 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 29 (9) , 1882-1887
Abstract
Background and Purpose —Polymorphism of the apolipoprotein E gene ( APOE ) may influence outcome after traumatic brain injury and intracerebral hemorrhage, with the ε4 allele being associated with poorer prognosis. We investigated APOE allele distribution in acute stroke and the effect of the ε4 allele on outcome. Methods — APOE genotypes were determined in 714 stroke patients: 640 ischemic stroke and 74 intracerebral hemorrhage patients. The survival effect of the ε4 allele was assessed with the use of a stratified log-rank test. A Cox proportional hazards regression model was used to estimate the independent effect of ε4 dose (0, 1, or 2) on survival, and logistic regression was used to determine the effect on 3-month outcome (good if alive at home, poor if in care or dead). Results —Allele distribution matched the general population with no difference between the ischemic and hemorrhagic groups. Survival in the entire cohort was unaffected by ε4 dose. Improved survival with increasing ε4 dose was found in the ischemic group (relative hazard=0.76 per allele; P =0.04). If transient ischemic attacks were excluded, a trend for improved survival persisted ( P =0.06). With intracerebral hemorrhage, a trend was seen toward reduced survival with ε4 ( P =0.07, log-rank test). Three-month outcome in the ischemic group was unaffected by ε4 dose, and a trend toward poorer outcome with ε4 was seen for intracerebral hemorrhage ( P =0.10). Conclusions —The APOE ε4 allele had divergent effects on survival and outcome in ischemic and hemorrhagic strokes in this population. The reported adverse effect on patients with intracerebral hemorrhage was supported. The favorable survival effect on ischemic stroke patients requires further study.Keywords
This publication has 32 references indexed in Scilit:
- High frequency of apolipoprotein E ϵ2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhageNeuroscience Letters, 1998
- Cerebral amyloid angiopathy and apolipoprotein E: Bad news for the good allele?Annals of Neurology, 1997
- Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the ratNeuropathology and Applied Neurobiology, 1996
- Case 22-1996New England Journal of Medicine, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Computerised record linkage: Compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological studyJournal of Clinical Epidemiology, 1995
- Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenariansAtherosclerosis, 1994
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991
- Polymorphism at the Apoprotein‐E locus in relation to risk of coronary diseaseClinical Genetics, 1984